Evidence map›Paper›PMID 40971113›Full record

Trial reportOdontology2026

Non-surgical periodontal treatment effects on IL-17 and IL-35 levels in smokers and non-smokers with periodontitis.

Taskaldiran Ezgi Sila, Tuter Gulay, Atak Yucel Aysegul, Yaman Melek

Registry-linked trialAbstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05281848 (Evaluation of the Effect of Non-surgical Periodontal Treatment on Salivary and Gingival Crevicular Fluid Levels of IL-17 and IL-35 in Periodontitis Patients as Smoker and Non-smoker), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05281848 nacompletednot on this map

Evaluation of the Effect of Non-surgical Periodontal Treatment on Salivary and Gingival Crevicular Fluid Levels of IL-17 and IL-35 in Periodontitis Patients as Smoker and Non-smoker

TypeinterventionalSponsorGazi UniversityRan2018 to 2022Enrolled55ConditionsPeriodontitis, Periodontal Diseases, Smoking, Smoking, TobaccoArmsNon-surgical periodontal treatment
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Role of IL-17 in Periodontitis and Its Systemic Connections.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Taskaldiran Ezgi SilaDepartment of Periodontology, Faculty of Dentistry, Istanbul Aydin University, Istanbul, Turkey.ORCID http://orcid.org/0000-0001-7580-4263
Tuter GulayDepartment of Periodontology, Faculty of Dentistry, Gazi University, Biskek Cad. 82. Sok. Emek, Ankara, Turkey. gulay@gazi.edu.tr.ORCID http://orcid.org/0000-0002-4264-0829
Atak Yucel AysegulDepartment of Immunology, Faculty of Medicine, Gazi University, Ankara, Turkey.ORCID http://orcid.org/0000-0001-5639-1096
Yaman MelekDepartment of Immunology, Faculty of Medicine, Gazi University, Ankara, Turkey.ORCID http://orcid.org/0000-0002-6281-0880

Funding

Gazi University Scientific Research Project Unit 03/2019-09
6 · The paper itself

Abstract

Periodontitis, a chronic inflammatory disease influenced by host-microbiota interactions, poses a significant global health burden. Smoking exacerbates periodontitis progression and impacts treatment outcomes. Interleukin (IL)-17 and IL-35 are key mediators of inflammation, yet their roles in smoking-related periodontitis and responses to non-surgical periodontal treatment (NSPT) remain underexplored. This clinical trial aimed to evaluate the effects of NSPT on salivary and gingival crevicular fluid (GCF) levels of IL-17 and IL-35 in smokers and non-smokers with periodontitis. A total of 55 subjects were divided into three groups: smokers with periodontitis (SP), non-smokers with periodontitis (NSP), and healthy controls (C). All subjects underwent comprehensive periodontal assessments and cytokine level analyses at baseline and four weeks post-NSPT. Saliva and GCF samples were analysed for IL-17 and IL-35 using enzyme-linked immunosorbent assay (ELISA). Statistical analyses evaluated group differences and correlations. After NSPT, both SP and NSP groups exhibited significant improvements in clinical parameters (p < 0.05). Salivary IL-17 and IL-35 levels did not show significant differences between the SP, NSP, and C groups after NSPT (p > 0.05). However, in GCF, IL-17 and IL-35 concentrations significantly increased in both SP and NSP groups following NSPT (p < 0.05). The total amount of GCF IL-17 decreased significantly only in the NSP group after NSPT (p < 0.05), while the total amount of GCF IL-35 increased significantly in both SP and NSP groups (p < 0.05). Strong correlations between IL-17 and IL-35 levels in both saliva and GCF were observed. NSPT modulates inflammatory and anti-inflammatory cytokine profiles, promoting improved clinical outcomes. The impact of smoking on cytokine responses highlights the need for further research to elucidate the mechanisms underlying these cytokine modulations and their role in periodontal therapy. Trial registration ClinicalTrials.gov ( https://clinicaltrials.gov -01.01.2018-NCT05281848).

Indexed as

Interleukin-17InterleukinsPeriodontitisSmokersSmokingAdultEnzyme-Linked Immunosorbent AssayFemaleGingival Crevicular FluidHumansMaleMiddle AgedNon-SmokersSalivaTreatment OutcomeInterleukin-17interleukin-35, humanInterleukinsGingival crevicular fluidInterleukin-17Interleukin-35Nonsurgical periodontal debridementPeriodontitisSalivaSmoking

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.